Works matching IS 20590105 AND DT 2020 AND VI 5 AND IP 1
Results: 113
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00261-9
- By:
- Publication type:
- Article
Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00257-5
- By:
- Publication type:
- Article
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00260-w
- By:
- Publication type:
- Article
Th17-related mammary immunity, but not a high systemic Th1 immune response is associated with protection against E. coli mastitis.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00258-4
- By:
- Publication type:
- Article
Malaria vaccine research & innovation: the intersection of IA2030 and zero malaria.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00252-w
- By:
- Publication type:
- Article
Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00255-7
- By:
- Publication type:
- Article
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00253-9
- By:
- Publication type:
- Article
The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00254-8
- By:
- Publication type:
- Article
Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00251-x
- By:
- Publication type:
- Article
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00256-6
- By:
- Publication type:
- Article
Navigating facilitated regulatory pathways during a disease X pandemic.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00249-5
- By:
- Publication type:
- Article
Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00247-7
- By:
- Publication type:
- Article
Author Correction: BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-0169-6
- By:
- Publication type:
- Article
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00248-6
- By:
- Publication type:
- Article
Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00241-z
- By:
- Publication type:
- Article
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00246-8
- By:
- Publication type:
- Article
Vaccine strategies for the Mtb/HIV copandemic.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00245-9
- By:
- Publication type:
- Article
Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00240-0
- By:
- Publication type:
- Article
Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00242-y
- By:
- Publication type:
- Article
Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Passive immunisation of convalescent human anti-Zika plasma protects against challenge with New World Zika virus in cynomolgus macaques.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00234-y
- By:
- Publication type:
- Article
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00243-x
- By:
- Publication type:
- Article
Ehrlichia chaffeensis and E. canis hypothetical protein immunoanalysis reveals small secreted immunodominant proteins and conformation-dependent antibody epitopes.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00231-1
- By:
- Publication type:
- Article
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00238-8
- By:
- Publication type:
- Article
Induction of protection in mice against a respiratory challenge by a vaccine formulated with exosomes isolated from Chlamydia muridarum infected cells.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00235-x
- By:
- Publication type:
- Article
Vaccination with the recombinant major outer membrane protein elicits long-term protection in mice against vaginal shedding and infertility following a Chlamydia muridarum genital challenge.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00239-7
- By:
- Publication type:
- Article
Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00232-0
- By:
- Publication type:
- Article
Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00236-w
- By:
- Publication type:
- Article
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00228-w
- By:
- Publication type:
- Article
Multicomponent gold nano-glycoconjugate as a highly immunogenic and protective platform against Burkholderia mallei.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00229-9
- By:
- Publication type:
- Article
Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00237-9
- By:
- Publication type:
- Article
Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00226-y
- By:
- Publication type:
- Article
Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00227-x
- By:
- Publication type:
- Article
Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00212-4
- By:
- Publication type:
- Article
Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00225-z
- By:
- Publication type:
- Article
A protective bivalent vaccine against Rift Valley fever and bluetongue.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00218-y
- By:
- Publication type:
- Article
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00223-1
- By:
- Publication type:
- Article
A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00220-4
- By:
- Publication type:
- Article
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00219-x
- By:
- Publication type:
- Article
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00224-0
- By:
- Publication type:
- Article
M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00222-2
- By:
- Publication type:
- Article
Sequential immunization induces strong and broad immunity against all four dengue virus serotypes.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00216-0
- By:
- Publication type:
- Article
Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00215-1
- By:
- Publication type:
- Article
Contagious Bovine and Caprine Pleuropneumonia: a research community's recommendations for the development of better vaccines.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00214-2
- By:
- Publication type:
- Article
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00221-3
- By:
- Publication type:
- Article
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00211-5
- By:
- Publication type:
- Article